At a glance
- Originator Kyowa Hakko
- Class Small molecules
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Diabetes mellitus
Most Recent Events
- 25 Oct 2006 Discontinued - Preclinical for Diabetes mellitus in Japan (unspecified route)
- 01 Dec 2004 Kyowa Hakko exclusively licensed to Sanwa Kagaku Kenkyusho rights to its research and know-how in the field of diabetes
- 01 Jul 2004 KF 72926 is available for licensing (http://www.kyowa.co.jp/eng/)